FDA Investigator Joseph L Despins, PhD

Joseph L Despins, PhD has inspections in 14 countries as of 22 Sep 2023. Joseph L Despins, PhD has collaborated with a combinined 4233 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
275
Last Inspection Date:
22 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Poland, Germany, Canada, India, France, Mexico, Japan, Spain, Italy, Russian Federation, United Kingdom of Great Britain and Northern Ireland, Switzerland, Argentina
Co-Investigator(s):
A Williams, Abdellah El Hajjam, Albert A Salvador, Amanda E Lewin, PhD, Amanda Jones, Anastasia I Offordile, Anastasia I Onuorah, Anastasia M Shields, Anita R Michael, Ann Marie Karnick, Ann Marie Montemurro, Anthony A Charity, Arindam Dasgupta, PhD, Audrey Thereset Uy, Austin B Appler, Beichner, Brandi L Garbutt, Brandon J Brookens, Brandy N Lepage, Brian D Young, Brian S Keefer, Brooke K Higgins, Brunilda Torres, Burnell M Henry, Byungja E Marciante, Calvin W Edwards, CDR Michael J Mero, Celia L Hutchinstein, Chamberlain, Charles M Edward, Charles M Edwards, Charles R Bonapace, PhD, Christina K Theodorou, Christine M Smith, Christopher R Richardson, Courtney N Long, Craig D Zagata, Crayton Lee, Cynthia Jim, CSO, Cynthia L Rakestraw, Cynthia White, Daniel L Aisen, Darlene C Plank Turlington, David J Hafner, David L Chon, Dawn D Aiello, Deborah G Haney Cozzone, Deborah H Cozzone, Debra J Bennett, Debra L Pagano, Derek S Dealy, Donald L Lech, Donyel M Jones, Dougherty, Dr. Abhijit Raha, PhD, Dr. Gang Wang, PhD, Dr. Mark J Seaton, PhD, Dung N Tran, Edward D Mcdonald, Edwin L Hobbs, Emmanuel A Dimaano, Jr, Eric J Cunningham, Eric L Vangraafeiland, Eric S Myskowski, Eric T Huebler, Erika M Wilkerson, Francis J Eng, Frank J Marciniak, Frank W Perrella, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Gayle S Lawson, Gene R Gunn, Geoffrey K Kilili, George Pyramides, Gerald W Kopp, Gess, Giovanni A Vigilante, H Ljamilla Selby, Hala L Selby, Hala Lj Whetstone, Hamiltonl, Haney, Hasan A Irier, PhD, Helen B Ricalde, Heriberto Negron Rivera, Himanshu Gupta, PhD, Ismael Olvera, IV, Jacob M Dyer, Jacqueline Mdiaz Albertini, James E Frye, James M Mason, James P Mcevoy, Janete F Guardia, Jason M Sluzynski, Javier E Santos, Jean M Kelahan, Jeannie R Mayberry, Jeen S Min, Jessica E Hensley, Joan A Loreng, John A Iwen, Jonee J Mearns, Joseph Joseph, L Despins, Joseph T Dougherty, Joshua C Schafer, Judith A Paterson, Judith Paterson, Julianne C Mccullough, Junho Pak, Justin B Holder, Kara A Scheibner, PhD, Karen A Briggs, Karthik B Iyer, Karyn M Campbell, Kavita C Dada, Kelly N Kerr, Kendra A Biddick, Kendra L Brooks, Kimberly A Dux, Kinh Q Mac, Kip J Hanks, Kristen D Evans, Kristen E Rescigno, Kristina Conroy, Kristina J Donohue, Kristina L Conroy, Kristina Mjoyce Pittman, Kurt A Brorson, PhD, Kyle S Hobson, LCDR Margaret E Digennaro, LCDR Susan E Polifko, Linda M Hoover, Lisa B Orr, Lisa Fecla, Lisa Feola, Lisa M Bellows, Loretta Nemchik, LT John M Mastalski, LTJG Bradley E Benasutti, LTJG Lauren N Shade, Luella J Rossi, Luella Rossi, Luis A Dasta, Makini Cobourne Duval, PhD, Makini K Cobourne Duval, Marc A Jackson, Jr, Marcelo O Mangalindan, Jr, Marcia Gelber, Marcus A Ray, Mary Ddavis Lopez, Mastalskij, Matthew R Noonan, Maureen A Wentzel, Maureen C Melvin, Meredith L Sheridan, Michael A Taylor, Michael D Omeara, Michael F Skelly, PhD, Michael Gurbarg, Michael J Nerz, Michael L Casner, Michael Rosner, Michael Serrano, Michele M Falchek, Mike M Rashti, Mohsen Rajabi Abhari, FDA, Morris Paul, Myrick, Nicholas J Morici, Nicola M Fenty Stewart, Nikhil Thakur, Nikisha M Bolden, Nina Yang, Niraj R Mehta, PhD, Osama M Hamoud, Pamela M Tremarki, Paula J Bretz, Phillip M Pontikos, Prabhu P Raju, Rachael O Oyewole, Raffi B Papazian, Richard E Needham, Rita F Larocca Mahoney, Robin P Mathew, Rochelle L Cross, Ronald A Stokes, Rose Ljean Mary, Roseline N Boateng, Ruben C Ayala, PharmD, Sam Pepe, Sarah J Park, Sean D Duke, Sean R Moynihan, MPH, Sena G Dissmeyer, Seongeun Cho (Julia), PhD, Sharon K Thoma, PharmD, Shelley L Waring, Shirley S Wen, Simone E Pitts, Stanley Au, State Agency, Stephanie Mangigian, MS/OSH, RN, Steven E Kane, Subramanian Muthukkumar, PhD, Sullivanm, Susan D Yuscius, Susan F Laska, MS, Susant Hadman, Tammy L Chavis, Tania E Vizcaino, Tekalign Wondimu, Temar Q Williams, Thomas E Friel, Thompsonv, Timothy J Schmidt, Todd J Maushart, Tonya O Corbin, Toyin B Oladimeji, Travers, Valerie G Vallely, Vlada Matusovsky, Walter L Fava, Whitney S Reynolds, William A Warnick, William F Lagud, Jr, William J Leonard, Xingfang Li, MD, Xinyi Hui, Yangmin Ning, Yiying E Chen, Yiyue Zhang (nmi), PhD, Young M Choi, PhD, Yvonne C Mcknight, Yvonne C Wood, Zhao Wang, PhD, Zhong Li, PhD

Joseph L Despins, PhD's Documents

Publish Date Document Type Title
March, 2022 FDA 483 Wanzhu Hou, CMD, MD (CN) - Form 483, 2022-03-17
April, 2003 EIR Therakos, Inc. - EIR, 2003-04-23
January, 2020 EIR Adam D. Cohen, MD - EIR, 2020-01-10
November, 2021 EIR Incyte Corporation - EIR, 2021-11-15
August, 2013 FDA 483 Janssen Research & Development, LLC - Form 483, 2013-08-09
June, 2004 FDA 483 Synthes USA - Form 483, 2004-06-18
July, 2007 FDA 483 Keystone Food Products, Inc. - Form 483, 2007-07-18
June, 2013 EIR QPS, LLC - EIR, 2013-06-21
June, 2019 FDA 483 Keystone Bioanalytical, Inc. - Form 483, 2019-06-28
August, 2012 FDA 483 Elahi, Dariush, Ph.D. - Form 483, 2012-08-27
October, 2010 FDA 483 Janssen Research & Development, LLC - Form 483, 2010-10-26
June, 2019 FDA 483 Response Keystone Bioanalytical, Inc. - Form 483R, 2019-07-10
April, 2018 EIR Frontage Laboratories, Inc. - EIR, 2018-04-20
September, 2012 EIR Auxilium Pharmaceuticals, Inc. - EIR, 2012-09-19
August, 2018 EIR Almac Clinical Services, LLC - EIR, 2018-08-01
May, 2016 EIR Bracket Global, LLC - EIR, 2016-05-05
September, 2009 EIR Auxilium Pharmaceuticals, Inc. - EIR, 2009-09-30
July, 2007 EIR Keystone Food Products, Inc. - EIR, 2007-07-18
June, 2013 FDA 483 Response QPS, LLC - Form 483R, 2013-07-11
February, 2008 EIR Popova, Veronika B., M.D. - EIR, 2011-07-05
September, 2012 EIR Frontida BioPharm Inc. - EIR, 2012-09-13
April, 2011 FDA 483 Janssen Therapeutics, A Division of Janssen Products, LP, Janssen R&D, LLC - Form 483, 2011-04-14
September, 2008 EIR Janssen Research & Development, LLC - EIR, 2008-09-12
December, 2010 FDA 483 Johnson & Johnson Consumer Inc. - Form 483, 2010-12-09
October, 2014 EIR QPS, LLC - EIR, 2014-10-24
June, 2006 EIR Chandler, Bronell E., M.D. - EIR, 2006-06-12
June, 2019 EIR Keystone Bioanalytical, Inc. - EIR, 2019-06-28
June, 2017 FDA 483 Pharmaron (Exton) Lab Services LLC - Form 483, 2017-06-09
June, 2017 EIR Lannett Company, Inc. - EIR, 2017-06-22
October, 2014 FDA 483 Response QPS, LLC - Form 483R, 2014-11-14
June, 2004 EIR Synthes USA - EIR, 2004-06-18
September, 2008 FDA 483 Janssen Research & Development, LLC - Form 483, 2008-09-12
December, 2010 FDA 483 Response Johnson & Johnson Consumer Inc. - Form 483R, 2011-01-07
August, 2017 EIR QPS, LLC - EIR, 2017-08-25
December, 2003 EIR Nemours AI duPont Hospital for Children DE IRB - EIR, 2003-12-08
September, 2011 FDA 483 Synthes, Inc. - Form 483, 2011-09-15
January, 2019 EIR QPS, LLC - EIR, 2019-01-16
August, 2013 EIR Janssen Research & Development, LLC - EIR, 2013-08-09
June, 2003 EIR Howard J. Eisen, MD - EIR, 2003-06-09
October, 2014 FDA 483 QPS, LLC - Form 483, 2014-10-24
June, 2013 FDA 483 QPS, LLC - Form 483, 2013-06-21
October, 2020 FDA 483 Patricia Kropf MD - Form 483, 2020-11-13
July, 2018 FDA 483 DermAvance Pharmaceuticals, Inc. - Form 483, 2018-07-17
December, 2004 FDA 483 Harris Consulting, Inc. - Form 483, 2004-12-17
June, 2023 FDA 483 Suken A. Shah, MD - Form 483, 2023-06-01

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more